{"id":"https://openalex.org/W2591069571","doi":"https://doi.org/10.1200/jco.2013.31.15_suppl.2550","title":"Phase Ib trial of combining aldoxorubicin plus doxorubicin.","display_name":"Phase Ib trial of combining aldoxorubicin plus doxorubicin.","publication_year":2013,"publication_date":"2013-05-20","ids":{"openalex":"https://openalex.org/W2591069571","doi":"https://doi.org/10.1200/jco.2013.31.15_suppl.2550","mag":"2591069571"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2013.31.15_suppl.2550","doi":"https://doi.org/10.1200/jco.2013.31.15_suppl.2550","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2013.31.15_suppl.2550","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5008969784","display_name":"Kamalesh Kumar Sankhala","orcid":"https://orcid.org/0009-0008-3351-0580","observed_orcids":["https://orcid.org/0009-0008-3351-0580"]},"institutions":[{"id":"https://openalex.org/I165951966","display_name":"The University of Texas at San Antonio Health Science Center","ror":"https://ror.org/02f6dcw23","country_code":"US","type":"education","lineage":["https://openalex.org/I165951966","https://openalex.org/I45438204"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kamalesh Kumar Sankhala","raw_affiliation_strings":["University of Texas Health Science Center at San Antonio, San Antonio, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Texas Health Science Center at San Antonio, San Antonio, TX","institution_ids":["https://openalex.org/I165951966"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073906112","display_name":"Sant P. Chawla","orcid":"https://orcid.org/0000-0002-9522-6744","observed_orcids":["https://orcid.org/0000-0002-9522-6744"]},"institutions":[{"id":"https://openalex.org/I4210104185","display_name":"Sarcoma Oncology Center","ror":"https://ror.org/01k15w004","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210104185"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sant P. Chawla","raw_affiliation_strings":["Sarcoma Oncology Center, Santa Monica, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sarcoma Oncology Center, Santa Monica, CA","institution_ids":["https://openalex.org/I4210104185"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007128913","display_name":"Victoria S. Chua","orcid":"https://orcid.org/0009-0009-2651-3625","observed_orcids":["https://orcid.org/0009-0009-2651-3625"]},"institutions":[{"id":"https://openalex.org/I4210104185","display_name":"Sarcoma Oncology Center","ror":"https://ror.org/01k15w004","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210104185"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Victoria S Chua","raw_affiliation_strings":["Sarcoma Oncology Center, Santa Monica, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sarcoma Oncology Center, Santa Monica, CA","institution_ids":["https://openalex.org/I4210104185"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072718710","display_name":"Doris M Quon","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210104185","display_name":"Sarcoma Oncology Center","ror":"https://ror.org/01k15w004","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210104185"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Doris Quon","raw_affiliation_strings":["Sarcoma Oncology Center, Santa Monica, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sarcoma Oncology Center, Santa Monica, CA","institution_ids":["https://openalex.org/I4210104185"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035253261","display_name":"Allison Bonk","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210104185","display_name":"Sarcoma Oncology Center","ror":"https://ror.org/01k15w004","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210104185"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Allison Bonk","raw_affiliation_strings":["Sarcoma Oncology Center, Santa Monica, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sarcoma Oncology Center, Santa Monica, CA","institution_ids":["https://openalex.org/I4210104185"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113800143","display_name":"Vivek Narasimhan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210104185","display_name":"Sarcoma Oncology Center","ror":"https://ror.org/01k15w004","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210104185"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Vivek Narasimhan","raw_affiliation_strings":["Sarcoma Oncology Center, Santa Monica, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sarcoma Oncology Center, Santa Monica, CA","institution_ids":["https://openalex.org/I4210104185"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023668376","display_name":"Monish Sodhi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210104185","display_name":"Sarcoma Oncology Center","ror":"https://ror.org/01k15w004","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210104185"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Monish Sodhi","raw_affiliation_strings":["Sarcoma Oncology Center, Santa Monica, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sarcoma Oncology Center, Santa Monica, CA","institution_ids":["https://openalex.org/I4210104185"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Nina Krishna","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210104185","display_name":"Sarcoma Oncology Center","ror":"https://ror.org/01k15w004","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210104185"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nina Krishna","raw_affiliation_strings":["Sarcoma Oncology Center, Santa Monica, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sarcoma Oncology Center, Santa Monica, CA","institution_ids":["https://openalex.org/I4210104185"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061894822","display_name":"Hillary Dinh","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I909123340","display_name":"CytRx (United States)","ror":"https://ror.org/02m8d5f73","country_code":"US","type":"company","lineage":["https://openalex.org/I909123340"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hillary Dinh","raw_affiliation_strings":["CytRx Corporation, Los Angeles, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CytRx Corporation, Los Angeles, CA","institution_ids":["https://openalex.org/I909123340"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028124406","display_name":"Scott Wieland","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I909123340","display_name":"CytRx (United States)","ror":"https://ror.org/02m8d5f73","country_code":"US","type":"company","lineage":["https://openalex.org/I909123340"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Scott Wieland","raw_affiliation_strings":["CytRx Corporation, Los Angeles, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CytRx Corporation, Los Angeles, CA","institution_ids":["https://openalex.org/I909123340"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5108606886","display_name":"Daniel J. Levitt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I909123340","display_name":"CytRx (United States)","ror":"https://ror.org/02m8d5f73","country_code":"US","type":"company","lineage":["https://openalex.org/I909123340"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel Levitt","raw_affiliation_strings":["CytRx Corporation, Los Angeles, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CytRx Corporation, Los Angeles, CA","institution_ids":["https://openalex.org/I909123340"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"31","issue":"15_suppl","first_page":"2550","last_page":"2550"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.6362000107765198,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.6362000107765198,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.0754999965429306,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.0348999984562397,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/doxorubicin","display_name":"doxorubicin","score":0.9980000257492065},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.8640000224113464},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.7870000004768372},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.9509999752044678},{"id":"https://openalex.org/keywords/advanced-solid-tumors","display_name":"advanced solid tumors","score":0.7770000100135803},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.8970000147819519},{"id":"https://openalex.org/keywords/thrombocytopenia","display_name":"thrombocytopenia","score":0.9800000190734863},{"id":"https://openalex.org/keywords/anemia","display_name":"anemia","score":0.6320000290870667},{"id":"https://openalex.org/keywords/febrile-neutropenia","display_name":"febrile neutropenia","score":0.9179999828338623},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.546999990940094},{"id":"https://openalex.org/keywords/malignant-fibrous-histiocytoma","display_name":"malignant fibrous histiocytoma","score":0.8119999766349792},{"id":"https://openalex.org/keywords/ovarian-cancer","display_name":"ovarian cancer","score":0.4059999883174896},{"id":"https://openalex.org/keywords/pancreatic-cancer","display_name":"pancreatic cancer","score":0.8980000019073486},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.4259999990463257}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8770158886909485},{"id":"https://openalex.org/C2781303535","wikidata":"https://www.wikidata.org/wiki/Q18936","display_name":"Doxorubicin","level":3,"score":0.7880233526229858},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.6794986128807068},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.6296889781951904},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5610901117324829},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.47335243225097656},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4434869587421417},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.42363452911376953},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3599257469177246},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.3241533041000366}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2013.31.15_suppl.2550","doi":"https://doi.org/10.1200/jco.2013.31.15_suppl.2550","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2013.31.15_suppl.2550","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1520073491","https://openalex.org/W2653565671","https://openalex.org/W2599952618","https://openalex.org/W2890637708","https://openalex.org/W2337234022","https://openalex.org/W7162627649","https://openalex.org/W2085976019","https://openalex.org/W1967378899","https://openalex.org/W2037125902","https://openalex.org/W2305040502"],"abstract_inverted_index":{"2550":[0],"Background:":[1],"Aldoxorubicin":[2],"is":[3,126,335,348],"a":[4,66,136,304,357],"novel":[5],"drug":[6,55],"that":[7,31],"covalently":[8],"binds":[9],"to":[10,121,157,212,225,328,365,367],"albumin":[11],"in":[12,17,23,47,76,262,271,300,307],"the":[13,62,127,143,155,178,293,351,368],"circulation":[14],"with":[15,50,78,330,341],"release":[16],"low":[18],"pH":[19],"environments.":[20],"Preclinical":[21],"studies":[22],"pancreatic":[24],"and":[25,43,71,177,186,250,281,303,337],"ovarian":[26],"tumor":[27,45],"xenograft":[28],"models":[29,49],"demonstrated":[30],"aldoxorubicin":[32,75,90,185,317,347,354],"plus":[33],"doxorubicin":[34,70,104,189,321,361],"administered":[35,56,91,191,327,355],"at":[36,57,92,154,236],"50%":[37],"of":[38,65,69,74,89,115,146,169,195,201,316,346,350,353,370],"their":[39,58],"MTD":[40,125,156,179,352],"provided":[41],"complete":[42],"prolonged":[44],"remission":[46],"these":[48],"less":[51],"toxicity":[52,63,139,334,369],"than":[53],"each":[54],"MTD.":[59],"We":[60],"evaluated":[61],"profile":[64],"fixed":[67],"dose":[68,128,137,145,238,345],"escalating":[72],"doses":[73],"subjects":[77,134,150,164,208,243,252,275,302,329],"advanced":[79],"solid":[80,331],"tumors.":[81,332],"Methods:":[82],"Phase":[83],"1b":[84],"open":[85],"label,":[86],"dose-escalation":[87],"study":[88],"either":[93,213],"175,":[94],"240":[95,102],"or":[96,101,142,217,231,247,256,273,286],"320":[97,147,183],"mg/m2":[98,103,184,188],"(130,":[99],"180,":[100],"equivalents)":[105],"iv":[106,190],"+":[107,320],"35":[108,187],"mg/m2doxorubicin":[109],"iv,":[110],"both":[111],"on":[112,192],"Day":[113,193],"1":[114,194,308],"21":[116,196],"day":[117,197],"cycles,":[118],"for":[119],"up":[120],"8":[122],"cycles.":[123,198],"The":[124,314,344],"level":[129],"immediately":[130],"below":[131],"where":[132],"2/6":[133],"experience":[135],"limiting":[138],"(DLT)":[140],",":[141],"maximum":[144],"mg/m2aldoxorubicin.":[148],"Additional":[149],"may":[151],"be":[152,325,339],"enrolled":[153],"provide":[158],"more":[159],"safety":[160],"data.":[161],"Results:":[162],"10":[163],"have":[165,204],"been":[166,205,297],"treated":[167],"as":[168,182,356],"January":[170],"21,":[171],"2013.":[172],"No":[173,220,283],"DLT":[174],"was":[175,180,222,234,288],"observed":[176],"defined":[181],"A":[199],"median":[200],"4.5":[202],"cycles":[203],"received.":[206],"3/10":[207,251,263],"were":[209],"terminated":[210,223],"due":[211,224],"progressive":[214],"disease":[215,299],"(2)":[216],"death":[218],"(1).":[219],"subject":[221,309],"an":[226],"adverse":[227,268],"event.":[228],"Grade":[229],"3":[230,246,255],"4":[232,248,257],"neutropenia":[233],"seen":[235,270],"all":[237],"levels":[239],"(8/10":[240],"subjects).":[241],"4/10":[242],"exhibited":[244],"grade":[245,254,266],"thrombocytopenia":[249],"had":[253],"anemia.":[258],"Neutropenic":[259],"fever":[260],"occurred":[261],"subjects.":[264],"Other":[265],"3/4":[267],"events":[269],"2":[272],"fewer":[274],"included":[276],"fatigue,":[277],"increased":[278],"liver":[279],"enzymes":[280],"dehydration.":[282],"significant":[284],"mucositis":[285],"cardiotoxicity":[287],"observed.":[289],"At":[290],"this":[291,371],"time":[292],"best":[294],"response":[295,306],"has":[296],"stable":[298],"6/10":[301],"partial":[305],"(malignant":[310],"fibrous":[311],"histiocytoma).":[312],"Conclusions:":[313],"combination":[315],"(320":[318],"mg/m2))":[319],"(35":[322],"mg/m2)":[323],"can":[324,338],"safely":[326],"Hematologic":[333],"common":[336],"controlled":[340],"growth":[342],"factors.":[343],"90%":[349],"single":[358],"agent.":[359],"Thus,":[360],"does":[362],"not":[363],"appear":[364],"add":[366],"combination.":[372],"Clinical":[373],"trial":[374],"information:":[375],"NCT01673438.":[376]},"counts_by_year":[{"year":2014,"cited_by_count":2}],"updated_date":"2026-09-27T08:07:27.782135","created_date":"2017-03-03T00:00:00"}